Incyte: Judges Skeptical of Incyte's Patent Block on Sun's Alopecia Drug

A Federal Circuit panel appeared likely to reverse a district court's order blocking Sun Pharmaceutical Industries Ltd. from launching its new alopecia drug, after questioning whether the projected harm to Incyte Corp.'s still-unapproved competing treatment was too speculative to justify the preliminary injunction.